From Cellular Aging to Tissue Protection: Epitalon in Regenerative and Longevity Medicine

Epitalon is a synthetic tetrapeptide derived from the amino acid composition of Epithalamin, a polypeptide extract derived from the bovine pineal gland. Current preclinical evidence suggests that Epitalon may activate telomerase by upregulating human telomerase reverse transcriptase (hTERT). In aged primates, Epitalon has also been associated with restoring evening melatonin synthesis and circadian cortisol rhythms. It has also been shown to enhance endogenous antioxidant defenses, including the activity of superoxide dismutase (SOD) and glutathione peroxidase. These mechanisms may be relevant to the future of regenerative medicine, as dysregulation of these pathways has been independently implicated in common musculoskeletal conditions, including osteoarthritis, disc degeneration, osteoporosis, and impaired tissue repair. In female mice, although Epitalon did not affect mean lifespan, the maximum lifespan increased by 12.3%. Evidence suggests that it may preserve retinal integrity in hereditary retinitis pigmentosa without reported adverse effects.[1] No human randomized controlled trials, pharmacokinetic studies, or registered trials of Epitalon have been reported at the time of this publication. The related polypeptide preparation Epithalamin, however, does have limited human studies in elderly patients. Epithalamin treatment was associated with a reduced incidence of cardiovascular and musculoskeletal disease, as well as decreased mortality over 6-8 years of follow-up.[2] This review synthesizes the available evidence on Epitalon in the context of regenerative medicine.